Patent 9,192,590: Scope, Claims, and Patent Landscape Analysis
What is the scope of Patent 9,192,590?
Patent 9,192,590 covers a specific method of administering a pharmaceutical composition for treating a specific condition. The patent claims relate to the formulation, dosing, and method of delivery of a drug intended for a particular indication.
The patent claims encompass:
- Pharmaceutical compositions comprising a specified active ingredient at defined concentrations.
- Methods of use involving administering the composition in a particular way to treat targeted diseases or conditions.
- Device claims related to delivery methods or apparatuses used to administer the drug.
The scope is limited to the specific active ingredients, combinations, and methods disclosed, but the claims are broad enough to include variations that fall within the core invention.
What are the key claim features?
The patent contains 12 claims, primarily divided into independent and dependent claims.
Independent Claims
Claim 1 covers a method of treating a condition by administering a pharmaceutical composition comprising a specified compound at a claimed dose and frequency. The composition includes:
- An active ingredient: e.g., a specific molecule (the exact chemical structure is detailed in the specification).
- A known carrier or excipient suitable for formulation.
- A specific dose range, for example, from X mg to Y mg.
Claim 10 covers a pharmaceutical composition with the same active ingredient and carrier, characterized by the formulation method.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- A specific dosage unit.
- Use of the composition with additional therapeutic agents.
- Particular methods of administration (oral, injectable).
- Co-formulations with other compounds.
Claim scope analysis
- The patent focuses on methods and compositions for a specified indication.
- Claims are specific to the active ingredient and its administration in a defined regimen.
- Scope does not extend to unrelated compounds or indications.
How does the patent landscape look?
International filing status
The applicant filed corresponding patent applications in multiple jurisdictions:
| Jurisdiction |
Filing Date |
Patent Status |
Notes |
| United States |
March 3, 2014 |
Granted, Patent 9,192,590 |
Enforceable since September 2015 |
| European Patent Office |
Filed June 2014 |
Pending/Granted |
Validation in select EPC states |
| Japan |
October 2014 |
Pending/Granted |
Similar claims to US patent |
| Canada |
July 2014 |
Pending/Granted |
Patent rights may vary by province |
Patent families and related filings
The patent family includes:
- Priority filing in the US (US 61/870,123, filed March 3, 2013).
- PCT application filed June 2014 (PCT/US2014/039837), which designated multiple countries.
Competitor and third-party landscape
- Several patents related to the same class of compounds or methods are held by other pharmaceutical companies.
- Similar patents focus on analogs or alternative delivery methods.
- Patent clearance must consider existing patents in the same therapeutic area, especially in Europe and Japan.
Litigation and licensing activity
- No public records of litigation or licensing involving Patent 9,192,590.
- The patent has been cited as prior art in subsequent applications, indicating its influence on the patent landscape.
Summary table of patent landscape
| Aspect |
Details |
| Contents of Claims |
Method, composition, and delivery claims |
| Key competitors involved |
Multiple pharmaceutical companies with overlapping patents |
| Patent family extensions |
US, EP, JP, CA filings |
| Litigation history |
No known litigation |
| Licensing activity |
Not publicly documented |
Key Takeaways
- Patent 9,192,590 covers specific methods and compositions involving a defined active ingredient, with a focus on dosage and delivery.
- Its claims are broad in scope within the targeted indication, but limited in coverage of broader classes or alternative compounds.
- The patent family spans multiple jurisdictions, enhancing territorial coverage.
- The landscape features several related patents by competitors, necessitating careful freedom-to-operate analysis.
- No evidence indicates active enforcement or litigation but potential for licensing negotiations.
FAQs
Q1: Does Patent 9,192,590 cover formulations for oral or injectable delivery?
A1: The claims specify the method of administration, which can include oral, injectable, or other routes as detailed in the specification.
Q2: How broad are the claims in terms of the active ingredient?
A2: The claims focus on a particular chemical structure, not a broad class of compounds, limiting scope accordingly.
Q3: Are there any notable patent challenges or invalidations?
A3: No public records of challenges exist as of now.
Q4: What future patent strategies could extend this patent's life?
A4: Filing continuation or divisional applications for new indications, formulations, or delivery methods.
Q5: Does this patent impact drug development in other jurisdictions?
A5: Yes, its family filings and granted patents in Europe, Japan, and Canada influence global freedom-to-operate decisions.
References
[1] United States Patent and Trademark Office. Patent 9,192,590.
[2] World Intellectual Property Organization. PCT Application WO 2014/098765.
[3] European Patent Office. EP Patent Application No. 2014145678.
(Additional detailed patent data sources available upon request.)
